These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18700135)

  • 1. A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease.
    Tukiainen T; Tynkkynen T; Mäkinen VP; Jylänki P; Kangas A; Hokkanen J; Vehtari A; Gröhn O; Hallikainen M; Soininen H; Kivipelto M; Groop PH; Kaski K; Laatikainen R; Soininen P; Pirttilä T; Ala-Korpela M
    Biochem Biophys Res Commun; 2008 Oct; 375(3):356-61. PubMed ID: 18700135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.
    Song F; Poljak A; Smythe GA; Sachdev P
    Brain Res Rev; 2009 Oct; 61(2):69-80. PubMed ID: 19464319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H NMR metabonomics of plasma lipoprotein subclasses: elucidation of metabolic clustering by self-organising maps.
    Suna T; Salminen A; Soininen P; Laatikainen R; Ingman P; Mäkelä S; Savolainen MJ; Hannuksela ML; Jauhiainen M; Taskinen MR; Kaski K; Ala-Korpela M
    NMR Biomed; 2007 Nov; 20(7):658-72. PubMed ID: 17212341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse.
    Jiang N; Yan X; Zhou W; Zhang Q; Chen H; Zhang Y; Zhang X
    J Proteome Res; 2008 Sep; 7(9):3678-86. PubMed ID: 18656976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
    Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
    Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy.
    Daykin CA; Foxall PJ; Connor SC; Lindon JC; Nicholson JK
    Anal Biochem; 2002 May; 304(2):220-30. PubMed ID: 12009699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prospective memory deficits in mild cognitive impairment of suspected Alzheimer's disease etiology using a novel event-based prospective memory task.
    Blanco-Campal A; Coen RF; Lawlor BA; Walsh JB; Burke TE
    J Int Neuropsychol Soc; 2009 Jan; 15(1):154-9. PubMed ID: 19128540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: the impact of quantitative magnetization transfer MR imaging.
    Kiefer C; Brockhaus L; Cattapan-Ludewig K; Ballinari P; Burren Y; Schroth G; Wiest R
    Neuroimage; 2009 Dec; 48(4):657-67. PubMed ID: 19607926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of C-18 unsaturated fatty acids using natural abundance deuterium 2D NMR spectroscopy in chiral oriented solvents.
    Lesot P; Baillif V; Billault I
    Anal Chem; 2008 Apr; 80(8):2963-72. PubMed ID: 18327921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.
    Greenberg N; Grassano A; Thambisetty M; Lovestone S; Legido-Quigley C
    Electrophoresis; 2009 Apr; 30(7):1235-9. PubMed ID: 19288586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
    Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment: believe it or not?
    Allegri RF; Glaser FB; Taragano FE; Buschke H
    Int Rev Psychiatry; 2008 Aug; 20(4):357-63. PubMed ID: 18925484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semantic inhibition impairment in mild cognitive impairment: a distinctive feature of upcoming cognitive decline?
    Bélanger S; Belleville S
    Neuropsychology; 2009 Sep; 23(5):592-606. PubMed ID: 19702413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool.
    Ala-Korpela M
    Expert Rev Mol Diagn; 2007 Nov; 7(6):761-73. PubMed ID: 18020906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False recognition helps to distinguish patients with Alzheimer's disease and amnestic MCI from patients with other kinds of dementia.
    Hildebrandt H; Haldenwanger A; Eling P
    Dement Geriatr Cogn Disord; 2009; 28(2):159-67. PubMed ID: 19696484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal surface analysis in subjective memory impairment, mild cognitive impairment and Alzheimer's dementia.
    Tepest R; Wang L; Csernansky JG; Neubert P; Heun R; Scheef L; Jessen F
    Dement Geriatr Cogn Disord; 2008; 26(4):323-9. PubMed ID: 18841017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.
    Rozzini L; Vicini Chilovi B; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):261-7. PubMed ID: 19017783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum.
    Wei L; Liao P; Wu H; Li X; Pei F; Li W; Wu Y
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):417-29. PubMed ID: 18164359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.